| Authors: |
Neubauer C; Bionorica SE, Neumarkt, Germany., Kragl M; Bionorica SE, Neumarkt, Germany., Braun T; ADSI - Austrian Drug Screening Institute GmbH, Innsbruck, Austria., Filipek P; ADSI - Austrian Drug Screening Institute GmbH, Innsbruck, Austria., Rad EB; Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria., Grander J; Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria., Mähler N; Bionorica SE, Neumarkt, Germany., Moritz K; Bionorica SE, Neumarkt, Germany., Hoch S; Bionorica SE, Neumarkt, Germany., Ziegler R; Bionorica SE, Neumarkt, Germany., Andreev S; Bionorica SE, Neumarkt, Germany., Steindl H; Bionorica SE, Neumarkt, Germany., Jakschitz T; ADSI - Austrian Drug Screening Institute GmbH, Innsbruck, Austria., Koeberle A; Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria., Bonn G; ADSI - Austrian Drug Screening Institute GmbH, Innsbruck, Austria., Soeberdt M; Bionorica SE, Neumarkt, Germany., Abels C; Bionorica SE, Neumarkt, Germany. |
